Changchun High-Tech

Changchun High-Tech Group was established in June 1993 and listed on the Shenzhen Stock Exchange’s main board in December 1996, becoming one of the earliest listed companies in Northeast China.

Changchun High-Tech Group was established in June 1993 and listed on the Shenzhen Stock Exchange’s main board in December 1996, becoming one of the earliest listed companies in Northeast China.

Changchun High-Tech Industry Co., Ltd. reports a decline in sales and revenue for the nine months ended September 30, 2026. The company’s sales and revenue both total **CNY 8,251.04 million**, down from **CNY 9,806.61 million** in the same period the prior year. The earnings update highlights a notable year-over-year decrease in financial performance.

Oct 2026MarketScreenerNews article

Changchun High-Tech Industry Group Co (stock code **000661.SZ**) sees its shares increase by **5.40%** on a single trading day. The company operates in high-tech industrial sectors, though specific drivers for the rise are not detailed in the report.

Oct 2026Global Banking & Finance ReviewNews article

Changchun High-Tech Industry receives approval from China’s National Medical Products Administration for the clinical trial of its GenSci161 injection. The filing was submitted via the Shenzhen Stock Exchange. The drug candidate advances toward human testing under regulatory oversight.

Oct 2026MarketScreenerNews article

GENSCI Singapore, an indirect subsidiary of Changchun High-Tech Industry, has acquired global rights to its medroxyprogesterone acetate oral suspension. The drug targets anorexia in AIDS patients, as stated in a regulatory filing. The move expands access to the treatment under GENSCI’s management.

Oct 2026MarketScreener IndiaNews article